Research Papers:
Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2125 views | HTML 3814 views | ?
Abstract
Hellen Kuasne1,2,*, Mateus C. Barros-Filho1,*, Ariane Busso-Lopes1, Fábio A. Marchi1, Maisa Pinheiro1, Juan J. M. Muñoz1, Cristovam Scapulatempo-Neto3, Eliney F. Faria4, Gustavo C. Guimarães5, Ademar Lopes5, José C. S. Trindade-Filho2, Maria Aparecida C. Domingues6, Sandra A. Drigo2,*, Silvia R. Rogatto1,2,7,8,*
1CIPE-A. C. Camargo Cancer Center, São Paulo, Brazil
2Department of Urology, Faculty of Medicine, São Paulo State University-UNESP, Botucatu, São Paulo, Brazil
3Department of Pathology, Americas Centro Oncológico Integrado, Rio de Janeiro, Brazil
4Department of Urology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
5Department of Urology, A. C. Camargo Cancer Center, São Paulo, Brazil
6Department of Pathology, Faculty of Medicine, São Paulo State University-UNESP, Botucatu, São Paulo, Brazil
7Department of Clinical Genetics, Vejle Sygehus, Vejle, Denmark
8Institute of Regional Health, University of Southern Denmark, Denmark
*These authors contributed equally to this work
Correspondence to:
Silvia R. Rogatto, email: [email protected], [email protected]
Keywords: penile carcinoma, micro-RNA, integrative analysis, HPV infection, lymph node metastasis
Received: September 18, 2016 Accepted: January 10, 2017 Published: January 21, 2017
ABSTRACT
Penile carcinoma (PeCa) is an important public health issue in poor and developing countries, and has only recently been explored in terms of genetic and epigenetic studies. Integrative data analysis is a powerful method for the identification of molecular drivers involved in cancer development and progression. miRNA and mRNA expression profiles followed by integrative analysis were investigated in 23 PeCa and 12 non-neoplastic penile tissues (NPT). Expression levels of eight miRNAs and 10 mRNAs were evaluated in the same set of samples used for microarray and in a validation set of cases (PeCa = 36; NPT = 27). Eighty-one miRNAs and 2,697 mRNAs were identified as differentially expressed in PeCa. Integrative data analysis revealed 255 mRNAs potentially regulated by 68 miRNAs. Using RT-qPCR, eight miRNAs and nine transcripts were confirmed as altered in PeCa. We identified that MMP1, MMP12 and PPARG and hsa-miR-31-5p, hsa-miR-224-5p, and hsa-miR-223-3p were able to distinguish tumors from NPT with high sensitivity and specificity. Higher MMP1 expression was detected as a better predictor of lymph node metastasis than the clinical-pathological data. In addition, PPARG and EGFR were highlighted as potential pathways for targeted therapy in PeCa. The analysis based on HPV positivity (7 of 23 cases) revealed five miRNA and 13 mRNA differentially expressed. Although in a limited number of cases, HPV positive PeCa presented less aggressive phenotype in comparison with negative cases. Overall, an integrative analysis using mRNA and miRNA profiles revealed markers related with tumor development and progression. Furthermore, MMP1 expression level was a predictive marker for lymph node metastasis in patients with PeCa.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14783